Ok

By continuing your visit to this site, you accept the use of cookies. These ensure the smooth running of our services. Learn more.

Covid-19 Impact on European In Vitro Diagnostic Market: Updated Study Offering Insights & Analysis up to 2026

SEP 16,2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the European In Vitro Diagnostic Market.

 

 

European In Vitro Diagnostics Market (Major Focus on Germany, France and The United Kingdom)

It should not come as a surprise that while the markets in Britain may face some fluctuations due to Brexit, major players in Britain are hopeful that with the new dynamics, newer opportunities will knock the doors of UK’s IVD market. Germany shall remain the market leader followed by France at No. 2 position, followed by Italy. Among the smaller nations, Poland, Czech Republic, Romania, Ireland and United Kingdom will show more growth than the remaining European nations. The report explores the opportunities and gaps in the top two IVD market of Europe as well as the most watched IVD market in 2018-2019, i.e., the UK.

On one hand the report deals with the Typology of out-of-pocket payments per country which varies in European member states which leads to varied payments by patients in different countries (impacts the cost of IVD tests) and on the other hand, it also looks at the attractive segments where IVD companies may come across decision makers and focus their marketing strategies accordingly. Infectious diseases, oncology, life style diseases shall remain the top three attractive segments in Europe.

Europe accounts for 23.4% of global cancer cases and 20.3% of cancer deaths, although it has only 9 per cent of the global population. Europe is characterized by striking geographical differences in cancer occurrence. There were an estimated 3.5 million new cancer cases and 1.9 million cancer deaths in Europe in 2012. Cancers of the female breast, colo-rectum, prostate and lung constitute over half of the overall incidences, while lung and colorectal cancer rank as the most common causes of cancer death. It widely varies from country to country.

In men, prostate cancer is the most frequent form of cancer incidence in most Northern, Western and Southern European countries, while lung cancer is the most frequently diagnosed cancer in Central and Eastern Europe. Lung cancer is the leading cause of cancer death among men in almost all European countries, while breast cancer dominates as the most frequent in women. Lung cancer is also a leading cause of cancer death in certain European countries among women, overtaking breast cancer.

European In Vitro Diagnostics Market - Segmentation

By Products & Services

  • Reagents & Kits
  • Equipment
  • New Technology/Connect Laboratories (AI in lab)
  • Data Management Services
  • Laboratory Support Services

By Technology

  • Immunohistochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Urinalysis
  • Hematology
  • Microbiology
  • POCT
  • Coagulation
  • Others

By Therapy Area

  • Infectious Diseases
  • Life Style Diseases (Diabetes, Obesity, etc)
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disorder &
  • Drug Testing

By End User

  • Hospital – Laboratories / ICU/ Care Units
  • Hospitals – Patient Bedside (POCT)
  • Advanced Clinical Laboratories (Referred by physicians)
  • Self-Tests / Walk ins
  • Research and Academic Laboratories
  • Home users/ Aged Care/ Long Term Care/Hospice/ Community Care

By Region

  • European Region (EU as single market)
  • Germany (As Country Market)
  • France (As Country Market)
  • The United Kingdom (As Country Market(

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The European In Vitro Diagnostic Market analysis report discusses the following heads in great detail:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • COVID-19 Impact Assessment
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Customization of the Report:

This report can be customized to meet the client’s requirements. In order to provide more accurate market forecast, all the reports are updated before delivery.

You can mail our sales team at (sales@stratviewresearch.com) and get in touch with us on +1-313-307-4176 to share your research requirements.

About Us: Stratview Research is a trusted global market intelligence and strategic consulting firm providing inclusive range of services to multiple clients across a wide array of industries. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.

 

 

 

 

 

 

The comments are closed.